Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-09

Clinical Trial Update: Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating the effects of benaglutide on weight and gut microbiota in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • benaglutide (benaglutide)

Snippet

Sponsor: Xiangya Hospital of Central South University | Conditions: Obesity | Phase 3 | Status: UNKNOWN